Galina A Erikson1,2, Neha Deshpande1,2, Balachandar G Kesavan1,2, Ali Torkamani1,2,3,4. 1. Scripps Health, La Jolla, California, USA. 2. Scripps Translational Science Institute, La Jolla, California, USA. 3. Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, California, USA. 4. Cypher Genomics, La Jolla, California, USA.
Abstract
PURPOSE: Copy-number variants have been associated with a variety of diseases, especially cancer, autism, schizophrenia, and developmental delay. The majority of clinically relevant events occur de novo, necessitating the interpretation of novel events. In this light, we present the Scripps Genome ADVISER CNV annotation pipeline and Web server, which aims to fill the gap between copy number variant detection and interpretation by performing in-depth annotations and functional predictions for copy number variants. METHODS: The Scripps Genome ADVISER CNV suite includes a Web server interface to a high-performance computing environment for calculations of annotations and a table-based user interface that allows for the execution of numerous annotation-based variant filtration strategies and statistics. RESULTS: The annotation results include details regarding location, impact on the coding portion of genes, allele frequency information (including allele frequencies from the Scripps Wellderly cohort), and overlap information with other reference data sets (including ClinVar, DGV, DECIPHER). A summary variant classification is produced (ADVISER score) based on the American College of Medical Genetics and Genomics scoring guidelines. We demonstrate >90% sensitivity/specificity for detection of pathogenic events. CONCLUSION: Scripps Genome ADVISER CNV is designed to allow users with no prior bioinformatics expertise to manipulate large volumes of copy-number variant data. Scripps Genome ADVISER CNV is available at http://genomics.scripps.edu/ADVISER/.
PURPOSE: Copy-number variants have been associated with a variety of diseases, especially cancer, autism, schizophrenia, and developmental delay. The majority of clinically relevant events occur de novo, necessitating the interpretation of novel events. In this light, we present the Scripps Genome ADVISER CNV annotation pipeline and Web server, which aims to fill the gap between copy number variant detection and interpretation by performing in-depth annotations and functional predictions for copy number variants. METHODS: The Scripps Genome ADVISER CNV suite includes a Web server interface to a high-performance computing environment for calculations of annotations and a table-based user interface that allows for the execution of numerous annotation-based variant filtration strategies and statistics. RESULTS: The annotation results include details regarding location, impact on the coding portion of genes, allele frequency information (including allele frequencies from the Scripps Wellderly cohort), and overlap information with other reference data sets (including ClinVar, DGV, DECIPHER). A summary variant classification is produced (ADVISER score) based on the American College of Medical Genetics and Genomics scoring guidelines. We demonstrate >90% sensitivity/specificity for detection of pathogenic events. CONCLUSION: Scripps Genome ADVISER CNV is designed to allow users with no prior bioinformatics expertise to manipulate large volumes of copy-number variant data. Scripps Genome ADVISER CNV is available at http://genomics.scripps.edu/ADVISER/.
Authors: Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan Journal: Genome Res Date: 2007-10-05 Impact factor: 9.043
Authors: Ganesh J Swaminathan; Eugene Bragin; Eleni A Chatzimichali; Manuel Corpas; A Paul Bevan; Caroline F Wright; Nigel P Carter; Matthew E Hurles; Helen V Firth Journal: Hum Mol Genet Date: 2012-09-08 Impact factor: 6.150
Authors: Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler Journal: Science Date: 2007-03-15 Impact factor: 47.728
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott Journal: Nucleic Acids Res Date: 2013-11-14 Impact factor: 16.971
Authors: Francisco Requena; Hamza Hadj Abdallah; Alejandro García; Patrick Nitschké; Sergi Romana; Valérie Malan; Antonio Rausell Journal: Nucleic Acids Res Date: 2021-07-02 Impact factor: 16.971
Authors: Kunal Bhutani; Kristopher L Nazor; Roy Williams; Ha Tran; Heng Dai; Željko Džakula; Edward H Cho; Andy W C Pang; Mahendra Rao; Han Cao; Nicholas J Schork; Jeanne F Loring Journal: Nat Commun Date: 2016-02-19 Impact factor: 14.919
Authors: S E Legge; M L Hamshere; S Ripke; A F Pardinas; J I Goldstein; E Rees; A L Richards; G Leonenko; L F Jorskog; K D Chambert; D A Collier; G Genovese; I Giegling; P Holmans; A Jonasdottir; G Kirov; S A McCarroll; J H MacCabe; K Mantripragada; J L Moran; B M Neale; H Stefansson; D Rujescu; M J Daly; P F Sullivan; M J Owen; M C O'Donovan; J T R Walters Journal: Mol Psychiatry Date: 2016-07-12 Impact factor: 15.992
Authors: A Urnikyte; I Domarkiene; S Stoma; L Ambrozaityte; I Uktveryte; R Meskiene; V Kasiulevičius; N Burokiene; V Kučinskas Journal: BMC Genet Date: 2016-05-04 Impact factor: 2.797